These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 323423)
1. Effect of apomorphine on schizophrenic symptoms. Smith RC; Tamminga C; Davis JM J Neural Transm; 1977; 40(2):171-6. PubMed ID: 323423 [TBL] [Abstract][Full Text] [Related]
2. Schizophrenic symptoms improve with apomorphine. Tamminga CA; Schaffer MH; Smith RC; Davis JM Science; 1978 May; 200(4341):567-8. PubMed ID: 347574 [TBL] [Abstract][Full Text] [Related]
3. Effects of intravenous and subcutaneous administration of apomorphine on the clinical symptoms of chronic schizophrenics. Syvälahti EK; Säkö E; Scheinin M; Pihlajamäki K; Hietala J Br J Psychiatry; 1986 Feb; 148():204-8. PubMed ID: 3516291 [TBL] [Abstract][Full Text] [Related]
11. Relationship of psychotic symptom clusters in schizophrenia to neuroleptic treatment and growth hormone response to apomorphine. Zemlan FP; Hirschowitz J; Sautter F; Garver DL Psychiatry Res; 1986 Jul; 18(3):239-55. PubMed ID: 2875478 [TBL] [Abstract][Full Text] [Related]
12. Drug-induced parkinsonism in schizophrenic patients: motor response and psychiatric changes after acute challenge with L-Dopa and apomorphine. Merello M; Starkstein S; Petracca G; Cataneo EA; Manes F; Leiguarda R Clin Neuropharmacol; 1996 Oct; 19(5):439-43. PubMed ID: 8889287 [TBL] [Abstract][Full Text] [Related]
13. Apomorphine and psychopathology. Lal S; De la Vega CE J Neurol Neurosurg Psychiatry; 1975 Jul; 38(7):722-6. PubMed ID: 1099172 [TBL] [Abstract][Full Text] [Related]
14. The use of dopamine agonists in the treatment of schizophrenia. Corsini GU; Pitzalis GF; Bernardi F; Bocchetta A; Del Zompo M Neuropharmacology; 1981 Dec; 20(12B):1309-13. PubMed ID: 7033816 [No Abstract] [Full Text] [Related]
15. The effect of apomorphine on regional cerebral blood flow in schizophrenia. Daniel DG; Berman KF; Weinberger DR J Neuropsychiatry Clin Neurosci; 1989; 1(4):377-84. PubMed ID: 2521086 [TBL] [Abstract][Full Text] [Related]
16. The effects of a dopamine agonist (apomorphine) on experimental and spontaneous pain in patients with chronic radicular pain: A randomized, double-blind, placebo-controlled, cross-over study. Haddad M; Pud D; Treister R; Suzan E; Eisenberg E PLoS One; 2018; 13(4):e0195287. PubMed ID: 29621293 [TBL] [Abstract][Full Text] [Related]
17. Effect of apomorphine on growth hormone and prolactin secretion in schizophrenic patients, with or without oral dyskinesia, withdrawn from chronic neuroleptic therapy. Ettigi P; Nair NP; Lal S; Cervantes P; Guyda H J Neurol Neurosurg Psychiatry; 1976 Sep; 39(9):870-6. PubMed ID: 993808 [TBL] [Abstract][Full Text] [Related]
18. Apomorphine in schizophrenia. Hollister LE; Davis KL; Berger PA Commun Psychopharmacol; 1980; 4(4):277-81. PubMed ID: 6115735 [No Abstract] [Full Text] [Related]
19. Schneider's first-rank symptoms of schizophrenia. An association with increased growth hormone response to apomorphine. Whalley LJ; Christie JE; Brown S; Arbuthnott GW Arch Gen Psychiatry; 1984 Nov; 41(11):1040-3. PubMed ID: 6497565 [TBL] [Abstract][Full Text] [Related]
20. Apomorphine has no effect on plasma homovanillic acid in schizophrenic patients. Davidson M; Kendler KS; Davis BM; Horvath TB; Mohs RC; Davis KL Psychiatry Res; 1985 Oct; 16(2):95-9. PubMed ID: 3865258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]